Analysts’ Viewpoint on Pericardial Patches Market Scenario
Pericardial patch is one of the primary therapeutic solutions for surgical treatments. Pericardial patches are either synthetic or biological. Large numbers of surgical procedures are performed every day to replace, repair, or regenerate tissues that have been damaged due to disease, trauma, or injury. Autologous pericardial patches are widely used materials for reconstruction in pediatric cardiac surgeries. The global pericardial patches market is witnessing advancements in manufacturing. Cardiac surgical interventions and spiral applications have increased the usage of pericardial patches. Rise in diseases related to surgical procedures is also likely to propel the global pericardial patches market in the near future.
Pericardial patches, which are used in various surgeries and disorders, reduce the rate of infection, control bleeding, increase biocompatibility, close defects, and offer durability. Furthermore, no calcification or shrinkage is observed with the usage of pericardial patches. Bovine pericardial patches, bovine pericardial valves, and other biological tissues have been used in cardiac surgeries since the past 50 years. Rise in prevalence of diseases related to surgical procedures is projected to drive the global pericardial patches market during the forecast period. Cardiac patches developed with advanced technologies provide a better treatment option for patients suffering from a heart attack. Advancements in fabrication technologies have led to the development of cardiac patches with excellent therapeutic performance and promising potential in promoting cardiac functions.
Request a sample to get extensive insights into the Pericardial Patches Market
Bovine pericardial patches are used in surgeries such as cardiovascular, eye surgery, dental, and hernia. Various types of patches are available in the market as per surgical requirements to prevent re-infection, close defects, and also for vascular reconstruction. Advancements in autologous, xenograft and synthetic patches have improved the durability and strength of pericardial patches. This is anticipated to propel the global market. Pericardial patches use EnCap AC technology in combination with durable and powerful bovine pericardium to provide improved biocompatibility and reliable treatment for various heart diseases. Advanced heart patches provide treatment options for patients suffering from a heart attack. According to an independent study, about 2,000 heart transplants are performed each year in the U.S. Thus, lucrative opportunities exist for stakeholders operating in the pericardial patches market.
In terms of product type, the global pericardial patches market has been classified into autologous, xenograft, and synthetic patches. The xenograft segment accounted for major share of the global market in 2021. The segment is anticipated to grow at a fast-paced CAGR from 2022 to 2031. Bovine xenograft pericardial patches are increasingly used in various surgical procedures due to their long-term stability and durability. Rise in demand for bovine xenograft pericardial patches can be ascribed to the low risk of restenosis, compliance near that of the host, and comfortable handling.
The cardiovascular surgery segment held major share of the global market in terms of revenue in 2021. This trend is likely to continue during the forecast period. Thousands of surgical procedures are performed every day to replace, repair, or regenerate tissues that have been damaged due to disease, trauma, or injury. Cardiovascular disease (CVD) is one of the leading causes of mortality and morbidity worldwide. Cardiac patches are among the primary therapeutic solutions for surgical treatments. Pericardial patches are primarily used for cardiovascular applications such as reconstruction of the aorta and pulmonary vessels, closure of interatrial defects, closure of interventricular defects, and reconstruction of atrioventricular valves.
Based on end-user, the global pericardial patches market has been bifurcated into hospitals and ambulatory surgical centers. The hospitals segment led the global market in terms of revenue in 2021. This trend is projected to continue during the forecast period. Availability of most of the pericardial patches in hospitals is anticipated to drive the segment during the forecast period. Increase in number of people suffering from congenital disorders and rise in per capita income is also expected to propel the segment.
In terms of region, the global pericardial patches market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for large share of the global market in 2021. This can be attributed to early adoption of technologically advanced products, increase in incidence of major surgical procedures, new product launches, and presence of key players in the region.
Asia Pacific is the fastest growing market for pericardial patches. The market in the region is anticipated to grow at a fast-paced CAGR from 2022 to 2031. Presence of developing countries with commercial hubs, expansion of biotech & pharma companies, increase in geriatric population in countries such as China and Japan, improvement in health care infrastructure, presence of a large number of soft tissue allograft manufacturers, and surge in investments are driving the market in Asia Pacific.
The global pericardial patches market is fragmented, with the presence of a large number of key players. Leading players operating in the global market include Edwards Lifesciences Corporation, Visionary Medtech Solutions, Abbott Laboratories, CryoLife, Inc., LeMaitre Vascular, Inc., Neovasc, Inc., FOC Medical, W. L. Gore & Associates, Inc., and Baxter Healthcare. Expansion of product portfolios and mergers and acquisitions are major strategies adopted by key players.
Request a custom report on Pericardial Patches Market
Each of these players has been profiled in the pericardial patches market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Attribute |
Detail |
Market Size Value in 2021 |
US$ 312.6 Mn |
Market Forecast Value in 2031 |
US$ 604.8 Mn |
Growth Rate (CAGR) |
6.9% |
Forecast Period |
2022–2031 |
Historical Data Available for |
2017–2021 |
Quantitative Units |
US$ Mn for Value |
Market Analysis |
It includes cross segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
The global pericardial patches market was valued at US$ 312.6 Mn in 2021
The global pericardial patches market is projected to reach more than US$ 604 Mn by 2031
The global pericardial patches market expanded at a CAGR of 3.9% from 2017 to 2021
The global pericardial patches market is anticipated to expand at a CAGR of 6.9% from 2022 to 2031
The xenograft segment accounted for more than 50% share of the global pericardial patches market in 2021
North America is expected to account for major share of the global pericardial patches market during the forecast period
Prominent players in the global pericardial patches market include Edwards Lifesciences Corporation, Visionary Medtech Solutions, Abbott, CryoLife, Inc., LeMaitre Vascular, Inc., Neovasc Inc., FOC Medical, W. L. Gore & Associates, Inc., and Baxter Healthcare
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pericardial Patches Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pericardial Patches Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Overview of Pericardial Patches Market
5.2. Technology advancements
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Pericardial Patches Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Autologous
6.3.2. Xenograft
6.3.2.1. Bovine
6.3.2.2. Porcine
6.3.2.3. Equine
6.3.3. Synthetic
6.4. Market Attractiveness Analysis, by Product Type
7. Global Pericardial Patches Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Cardiovascular Surgery
7.3.2. Dental Surgery
7.3.3. Ophthalmology
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Pericardial Patches Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Pericardial Patches Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Pericardial Patches Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Autologous
10.2.2. Xenograft
10.2.2.1. Bovine
10.2.2.2. Porcine
10.2.2.3. Equine
10.2.3. Synthetic
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Cardiovascular Surgery
10.3.2. Dental Surgery
10.3.3. Ophthalmology
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Pericardial Patches Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Autologous
11.2.2. Xenograft
11.2.2.1. Bovine
11.2.2.2. Porcine
11.2.2.3. Equine
11.2.3. Synthetic
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Cardiovascular Surgery
11.3.2. Dental Surgery
11.3.3. Ophthalmology
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-Region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-Region
12. Asia Pacific Pericardial Patches Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Autologous
12.2.2. Xenograft
12.2.2.1. Bovine
12.2.2.2. Porcine
12.2.2.3. Equine
12.2.3. Synthetic
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Cardiovascular Surgery
12.3.2. Dental Surgery
12.3.3. Ophthalmology
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-Region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-Region
13. Latin America Pericardial Patches Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Autologous
13.2.2. Xenograft
13.2.2.1. Bovine
13.2.2.2. Porcine
13.2.2.3. Equine
13.2.3. Synthetic
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Cardiovascular Surgery
13.3.2. Dental Surgery
13.3.3. Ophthalmology
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-Region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-Region
14. Middle East & Africa Pericardial Patches Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Autologous
14.2.2. Xenograft
14.2.2.1. Bovine
14.2.2.2. Porcine
14.2.2.3. Equine
14.2.3. Synthetic
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Cardiovascular Surgery
14.3.2. Dental Surgery
14.3.3. Ophthalmology
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-Region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-Region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Edwards Lifesciences Corporation
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. Abbott
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Baxter International
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Visionary medtech solutions
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. CryoLife, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Financial Overview
15.2.5.4. SWOT Analysis
15.2.5.5. Strategic Overview
15.2.6. LeMaitre Vascular, Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. SWOT Analysis
15.2.6.5. Strategic Overview
15.2.7. Neovasc Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. FOC Medical
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview
15.2.9. W. L. Gore & Associates, Inc.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. SWOT Analysis
15.2.9.5. Strategic Overview
15.2.10. Collagen Solutions Plc
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Financial Overview
15.2.10.4. SWOT Analysis
15.2.10.5. Strategic Overview
List of Tables
Table 01: Global Pericardial Patches Market Value (US$ Mn) Forecast, by Product Type 2017–2031
Table 02: Global Pericardial Patches Market Value (US$ Mn) Forecast, by Xenograft, 2017‒2031
Table 03: Global Pericardial Patches Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 04: Global Pericardial Patches Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 05: Global Pericardial Patches Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Pericardial Patches Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Pericardial Patches Market Value (US$ Mn) Forecast, by Product Type 2017–2031
Table 08: North America Pericardial Patches Market Value (US$ Mn) Forecast, by Xenograft, 2017‒2031
Table 09: North America Pericardial Patches Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 10: North America Pericardial Patches Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 11: Europe Pericardial Patches Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 12: Europe Pericardial Patches Market Value (US$ Mn) Forecast, by Product Type 2017–2031
Table 13: Europe Pericardial Patches Market Value (US$ Mn) Forecast, by Xenograft, 2017‒2031
Table 14: Europe Pericardial Patches Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 15: Europe Pericardial Patches Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 16: Asia Pacific Pericardial Patches Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 17: Asia Pacific Pericardial Patches Market Value (US$ Mn) Forecast, by Product Type 2017–2031
Table 18: Asia Pacific Pericardial Patches Market Value (US$ Mn) Forecast, by Xenograft, 2017‒2031
Table 19: Asia Pacific Pericardial Patches Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 20: Asia Pacific Pericardial Patches Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 21: Latin America Pericardial Patches Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 22: Latin America Pericardial Patches Market Value (US$ Mn) Forecast, by Product Type 2017–2031
Table 23: Latin America Pericardial Patches Market Value (US$ Mn) Forecast, by Xenograft, 2017‒2031
Table 24: Latin America Pericardial Patches Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 25: Latin America Pericardial Patches Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 26: Middle East & Africa Pericardial Patches Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 27: Middle East & Africa Pericardial Patches Market Value (US$ Mn) Forecast, by Product Type 2017–2031
Table 28: Middle East & Africa Pericardial Patches Market Value (US$ Mn) Forecast, by Xenograft, 2017‒2031
Table 29: Middle East & Africa Pericardial Patches Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 30: Middle East & Africa Pericardial Patches Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
List of Figures
Figure 01: Global Pericardial Patches Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Pericardial Patches Market Value Share, by Product Type, 2021
Figure 03: Global Pericardial Patches Market Value Share, by Application, 2021
Figure 04: Global Pericardial Patches Market Value Share, by End-user, 2021
Figure 05: Global Pericardial Patches Market, by Product Type, 2021 and 2031
Figure 06: Global Pericardial Patches Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 07: Global Pericardial Patches Market (US$ Mn), by Autologous, 2017–2031
Figure 08: Global Pericardial Patches Market (US$ Mn), by Xenograft, 2017–2031
Figure 09: Global Pericardial Patches Market (US$ Mn), by Synthetic, 2017–2031
Figure 10: Global Pericardial Patches Market, by Application, 2021 and 2031
Figure 11: Global Pericardial Patches Market Attractiveness Analysis, by Application, 2021–2031
Figure 12: Global Pericardial Patches Market (US$ Mn), by Cardiovascular Surgery, 2017–2031
Figure 13: Global Pericardial Patches Market (US$ Mn), by Dental Surgery, 2017–2031
Figure 14: Global Pericardial Patches Market (US$ Mn), by Ophthalmology, 2017–2031
Figure 15: Global Pericardial Patches Market (US$ Mn), by Others, 2017–2031
Figure 16: Global Pericardial Patches Market, by End-user, 2021 and 2031
Figure 17: Global Pericardial Patches Market Attractiveness Analysis, by End-user, 2021–2031
Figure 18: Global Pericardial Patches Market (US$ Mn), by Hospitals, 2017–2031
Figure 19: Global Pericardial Patches Market (US$ Mn), by Ambulatory Surgical Centers, 2017–2031
Figure 20: Global Pericardial Patches Market (US$ Mn), by Others, 2017–2031
Figure 21: Global Pericardial Patches Market Value Share Analysis, by Region, 2021 and 2031
Figure 22: Global Pericardial Patches Market Attractiveness Analysis, by Region, 2017–2031
Figure 23: North America Pericardial Patches Market Value (US$ Mn) Forecast, 2017–2031
Figure 24: North America Pericardial Patches Market Value Share Analysis, by Country, 2021 and 2031
Figure 25: North America Pericardial Patches Market Attractiveness Analysis, by Country, 2021–2031
Figure 26: North America Pericardial Patches Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 27: North America Pericardial Patches Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 28: North America Pericardial Patches Market Value Share Analysis, by Application, 2020 and 2031
Figure 29: North America Pericardial Patches Market Attractiveness Analysis, by Application, 2021–2031
Figure 30: North America Pericardial Patches Market Value Share Analysis, by End-user, 2021 and 2031
Figure 31: North America Pericardial Patches Market Attractiveness Analysis, by End-user, 2021–2031
Figure 32: Europe Pericardial Patches Market Value (US$ Mn) Forecast, 2017–2031
Figure 33: Europe Pericardial Patches Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 34: Europe Pericardial Patches Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 35: Europe Pericardial Patches Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 36: Europe Pericardial Patches Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 37: Europe Pericardial Patches Market Value Share Analysis, by Application, 2020 and 2031
Figure 38: Europe Pericardial Patches Market Attractiveness Analysis, by Application, 2021–2031
Figure 39: Europe Pericardial Patches Market Value Share Analysis, by End-user, 2021 and 2031
Figure 40: Europe Pericardial Patches Market Attractiveness Analysis, by End-user, 2021–2031
Figure 41: Asia Pacific Pericardial Patches Market Value (US$ Mn) Forecast, 2017–2031
Figure 42: Asia Pacific Pericardial Patches Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 43: Asia Pacific Pericardial Patches Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 44: Asia Pacific Pericardial Patches Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 45: Asia Pacific Pericardial Patches Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 46: Asia Pacific Pericardial Patches Market Value Share Analysis, by Application, 2020 and 2031
Figure 47: Asia Pacific Pericardial Patches Market Attractiveness Analysis, by Application, 2021–2031
Figure 48: Asia Pacific Pericardial Patches Market Value Share Analysis, by End-user, 2021 and 2031
Figure 49: Asia Pacific Pericardial Patches Market Attractiveness Analysis, by End-user, 2021–2031
Figure 50: Latin America Pericardial Patches Market Value (US$ Mn) Forecast, 2017–2031
Figure 51: Latin America Pericardial Patches Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 52: Latin America Pericardial Patches Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 53: Latin America Pericardial Patches Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 54: Latin America Pericardial Patches Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 55: Latin America Pericardial Patches Market Value Share Analysis, by Application, 2020 and 2031
Figure 56: Latin America Pericardial Patches Market Attractiveness Analysis, by Application, 2021–2031
Figure 57: Latin America Pericardial Patches Market Value Share Analysis, by End-user, 2021 and 2031
Figure 58: Latin America Pericardial Patches Market Attractiveness Analysis, by End-user, 2021–2031
Figure 59: Middle East & Africa Pericardial Patches Market Value (US$ Mn) Forecast, 2017–2031
Figure 60: Middle East & Africa Pericardial Patches Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 61: Middle East & Africa Pericardial Patches Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 62: Middle East & Africa Pericardial Patches Market Value Share Analysis, by Product Type, 2020 and 2031
Figure 63: Middle East & Africa Pericardial Patches Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 64: Middle East & Africa Pericardial Patches Market Value Share Analysis, by Application, 2020 and 2031
Figure 65: Middle East & Africa Pericardial Patches Market Attractiveness Analysis, by Application, 2021–2031
Figure 66: Middle East & Africa Pericardial Patches Market Value Share Analysis, by End-user, 2021 and 2031
Figure 67: Middle East & Africa Pericardial Patches Market Attractiveness Analysis, by End-user, 2021–2031